Clobenzorex (CBZ) is a stimulant drug, recognized for its anorectic potential, legally used in some countries for obesity treatment. However, CBZ is banned in much of the world and has been often used illegally by drivers needing to stay alert for extended periods. Therefore, the rapid identification of CBZ in forensic samples is of paramount importance for public health and safety. In this context, we introduce an innovative electroanalytical screening method for detecting CBZ in seized tablet samples and human oral fluid using voltammetry with a graphite screen-printed electrode (SPE-Gr). The electrochemical detection was optimized in phosphate buffer solution (0.1 mol L−1, pH 7.0) using square wave voltammetry (SWV). The SPE-Gr combined with SWV exhibited a good stability of the electrochemical responses for CBZ detection, with a relative standard deviation of less than 5% across different days (N = 5) and using different SPEs (N = 3). A linear detection range of 2.5–100.0 μmol/L (R2 = 0.992) was achieved, with a low limit of detection (LOD) of 0.32 μmol L−1. Interference studies with other illicit drugs and adulterants confirmed the selectivity of the proposed method for CBZ detection. In addition, the presence of CBZ in seized tablet samples and authentic oral fluids, collected from drivers, was detected and identified using the proposed method, which results were also confirmed by HPLC-MS. Consequently, integrating SPE-Gr with SWV offers a reliable, rapid, sensitive, selective, reproducible, and direct approach for the preliminary qualitative and quantitative analysis of CBZ in forensic contexts. Furthermore, the proposed method provides an efficient oral fluid test for CBZ screening in drivers under the influence of drugs.